-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on 10x Genomics, Raises Price Target to $32

Benzinga·04/20/2026 16:17:25
Listen to the news
Canaccord Genuity analyst Kyle Mikson maintains 10x Genomics (NASDAQ:TXG) with a Buy and raises the price target from $22 to $32.